Gsk Share Discussion Threads

[essentialinvestor] 25/4/2018 13:36

Free cashflow looks a tad disappointing to me, even allowing for the NVS payment.
This is still with a chunky Advair contribution.
Pipeline development may provide some support?.

[andyadvfn1] 25/4/2018 13:31

Bouncing around like a penny share, day traders will be loving it

[montyhedge] 25/4/2018 13:28

Trader Trouble is these figures were very disappointing also 10 year US is 3%Why take a risk for a extra 2% in dividends.High yield stocks I think will come off3% safe US bonds.

[davemac3] 25/4/2018 13:24

do I not like that!

[tradermichael] 25/4/2018 13:06

The Board intends to maintain the dividend for 2018 at the current level of 80p per share, subject to any material change in the external environment or performance expectations. Over time, as free cash flow strengthens, it intends to build free cash flow cover of the annual dividend to a target range of 1.25-1.50x, before returning the dividend to growth.

[tradermichael] 25/4/2018 12:56

Pick out of it what you may ........

Sales of Ellipta Respiratory products, £386 million +25% AER, +34% CER and Nucala £104 million +76% AER, +86% CER.

Continued growth from dolutegravir-based HIV products, including new 2 drug regimen Juluca, with sales of £964 million +15% AER, +23% CER.

Shingrix sales of £110 million

[montyhedge] 25/4/2018 12:52

Interesting to see what analyst make of it, eps down. Ok dividend 19p but thats no surprise.

[nigelpm] 25/4/2018 12:50

Definitely disappointing on first glance.

[tim 3] 25/4/2018 12:43

Short term trend was obviously strongly up,lets hope this does not change it.

Rest of the day and next couple of days will be key.

Will still hold regardless.

[action] 25/4/2018 12:43

SILVER LINING IS WATEVER THEY R BUYING WILL BE CHEAP AS STG IS STRONGER.

[alphorn] 25/4/2018 12:39

badtime - thx. You will be pleased to know they were not as big as in the bad old days when I scared most of the posters on the options thread!

[action] 25/4/2018 12:38

may have to wait till next divi now.lol.

[badtime] 25/4/2018 12:37

I'm not selling but not buying eitherAlps well done on your bearish positions

[romeike] 25/4/2018 12:37

Results in line with expectations. Not seeing anything to be disappointed about. Dividend maintained. Dollar won't stay weak for long.

[montyhedge] 25/4/2018 12:33

I like GSK, but these were disappointing.

[alphorn] 25/4/2018 12:28

romeike - I know that you have me filtered but it is the incremental product sales that is the focus. ie. new launches may only keep pace with products going off-patent - the difficulty is to launch enough new compounds and line extensions to grow the company. Very difficult with a pharma group of this size.

[dr biotech] 25/4/2018 12:24

Earnings just above estimates, currency hit seems quite large though. Nothing to get excited or depressed about.

[montyhedge] 25/4/2018 12:19

Disappointing I thought.

[romeike] 25/4/2018 12:19

progress with key new products looks strong

[alphorn] 25/4/2018 12:18

Breathing again a bit, as previously posted had opened bearish positions. Not as big as some in the past though!

[ny boy] 25/4/2018 12:16

Bear trap probably

[badtime] 25/4/2018 12:15

Yes it's the outlook that I zeroed in on

[alphorn] 25/4/2018 12:12

Look ok'ish'. Wishy washy outlook for obvious reasons that may restrain the sp?